Case Reports
Dapagliflozin-induced sweet syndrome
Affiliations
- PMID: 31603973
Item in Clipboard
Case Reports
Dapagliflozin-induced sweet syndrome
Cutis.
2019 Aug.
No abstract available
Similar articles
-
Empagliflozin and Major Renal Outcomes in Heart Failure.N Engl J Med. 2021 Oct 14;385(16):1531-1533. doi: 10.1056/NEJMc2112411. Epub 2021 Aug 27. N Engl J Med. 2021. PMID: 34449179 Clinical Trial. No abstract available.
-
Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.J Am Heart Assoc. 2018 Feb 10;7(4):e007046. doi: 10.1161/JAHA.117.007046. J Am Heart Assoc. 2018. PMID: 29440005 Free PMC article. Clinical Trial.
-
Dapagliflozin-induced hypercalcemia.Nefrologia (Engl Ed). 2018 May-Jun;38(3):336-337. doi: 10.1016/j.nefro.2017.06.009. Epub 2017 Aug 1. Nefrologia (Engl Ed). 2018. PMID: 28778537 English, Spanish. No abstract available.
-
Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.Curr Diabetes Rev. 2019;15(4):259-262. doi: 10.2174/1573399814666180726114044. Curr Diabetes Rev. 2019. PMID: 30047331 Review.
-
Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.Diabetes Metab Syndr. 2021 Jan-Feb;15(1):361-363. doi: 10.1016/j.dsx.2021.01.016. Epub 2021 Jan 23. Diabetes Metab Syndr. 2021. PMID: 33517150 Review. No abstract available.
Cited by
-
New Practical Aspects of Sweet Syndrome.Am J Clin Dermatol. 2022 May;23(3):301-318. doi: 10.1007/s40257-022-00673-4. Epub 2022 Feb 14. Am J Clin Dermatol. 2022. PMID: 35157247 Free PMC article. Review.
-
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.J Clin Med. 2024 Dec 31;14(1):188. doi: 10.3390/jcm14010188. J Clin Med. 2024. PMID: 39797270 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
